It will be important to test the extent to which GLIB treatment [at lower concentrations that are more specific for KATP channels in lymphatic muscle48] can restore impaired lymphatic function in other animal models of metabolic disease and if animals with lymphatic muscle deficient in Kir6.1 channels are resistant to the lymphatic contractile dysfunction associated with those models. Here, KCNJ8 is linked to metabolic disease.